Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pacesetter Systems was a pioneering medical technology company specializing in the development and manufacture of implantable cardiac rhythm management devices. Founded in 1969 by entrepreneur Alfred Mann, the company became a global leader in the pacemaker industry, introducing significant innovations in pulse generator longevity and programmability. The firm was acquired by Siemens in 1985 and subsequently sold to St. Jude Medical in 1994 for approximately $500 million. Its extensive portfolio of cardiac pacing and defibrillation technologies was eventually integrated into Abbott Laboratories following Abbott's acquisition of St. Jude Medical in 2017. Pacesetter is historically recognized for its critical role in advancing the reliability and sophistication of modern cardiac care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pacesetter Systems.